Effect of Myofascial Release on Menstrual Pain Post Caesarean Section
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: stretching exrcise, myofascial release.
- Who it may be relevant to
- Registry conditions: Menstrual Pain. Basic parameters: 20 years — 35 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to investigate the effect of myofascial release on menstrual pain post cesarean section.
Detailed description
Egypt has the highest cesarean section (CS) rate that has increased from 20% in 2005 to 52% in 2014. This exceptionally high CS rate without a corresponding improvement in maternal and child mortality suggests that although CS is available for populations at risk, numbers of medical unjustified CSs are on the rise.
The CS scar is assumed to be related to adverse clinical gynecological symptoms such as intermenstrual bleeding, dysmenorrhea, dyspareunia and chronic pelvic pain.The incidence of postpartum dysmenorrhea was significantly higher in the cesarean section delivery than in the vaginal delivery.
Cesarean scars have direct links to the perineal fascia and its connection with the transversalis fascia. These scars can interfere with fascial load distribution, which create adhesions to neighboring tissues, the abdominal and pelvic viscera and surrounding anatomical structures are then potentially disrupted, causing inadequate nutrition and inappropriately distributed tension among the various structures affected.
Fascial restrictions obviously decrease blood flow by vascular compression. When the dermis and fasciae are affected by a scar, the sliding structure of the fasciae is altered and when the scar tissues are not capable of adapting to the new stressor, their function is impaired.
MFR procedure lead to vasodilation by increasing capillary permeability. MFR directs force to fascial fibroblasts, as well as indirect strains applied to nerves, blood vessels, the lymphatic system and muscles. There is lacking of studies at this point, so the aim of the study is to investigate the effect of myofascial release on menstrual pain post CS.
Interventions
- Other stretching exrcise
The participants will receive stretching exercises program for 45 minutes, 3 days/week for 4 weeks. - Other myofascial release
The participants will receive the same stretching exercises program in addition to myofascial release of cesarean scar, abdominal fascia, diaphragm and psoas muscle for 30 minutes session twice a week for two weeks.
Primary outcome measures
- Menstrual pain intensity measurement [Time frame: 4 weeks]
- Menstruation aspects assessment [Time frame: 4 weeks]
- Abdominal tenderness assessment [Time frame: 4 weeks]
Secondary outcome measures (1)
- Scar tissue mobility assessment: [Time frame: 4 weeks]
Eligibility criteria
Inclusion criteria
- Women complaining of menstrual pain post - caesarean section (CS).
- Their age will range from 20 to 35 years.
- Their body mass index will range from 20-30 kg/m2.
- Women who gave birth once or twice.
- Women who had C-section 6 weeks to 6 months ago.
Exclusion criteria
- Active infection/ infectious skin disease, burn or scars.
- Less than six weeks after CS.
- Any abdominal surgeries other than CS.
- Any spinal deformity as scoliosis or kyphosis.
- History of cancer or radiation to the abdominopelvic region.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Nourhan Samir Ibrahim — Cairo
Identifiers
NCT: NCT06951763 · P.T.REC/012/005675